TOFACITINIB CITRATE
- Product NDC
- 84677-081
- Requested package NDC
- 84677-081-30
- 11-digit product format
- 846770081
- Labeler code
- 84677
- Product ID
- 84677-081_5dd4349f-edf9-2aec-e063-6394a90ab7a0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tofacitinib citrate
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Golden State Medical Supply, Inc.
- Application
- ANDA220972
- Marketing category
- ANDA
- Marketing start
- 2026-06-25
- Substance
- TOFACITINIB CITRATE
- Active strength
- 11 mg/1
- Pharmacologic classes
- Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A220972-001 | TOFACITINIB CITRATE | TOFACITINIB CITRATE | EQ 11MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2026-06-25 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A220972-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A220972-001 | TOFACITINIB CITRATE | EQ 11MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2026-06-25 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A220972-001 | TOFACITINIB CITRATE | EQ 11MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2026-06-25 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A220972-001 | TOFACITINIB CITRATE | EQ 11MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2026-06-25 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220972-001 | TOFACITINIB CITRATE | EQ 11MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2026-06-25 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A220972-001 | AB | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A220972-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A220972-001 | AB | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220972-001 | AB | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- TOFACITINIB CITRATE
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TOFACITINIB CITRATE | 11 mg/1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | Radha Pharmaceuticals, Inc. | 141ab3eb-982b-4242-89db-6ddce5be0c40 | 2026-07-21 | Boxed warning, Warnings, Adverse reactions | 220972 ANDA220972 |
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | ScieGen Pharmaceuticals, INC. | 11d08738-efa3-4474-8eda-812bc04adfbb | 2026-07-21 | Boxed warning, Warnings, Adverse reactions | 220972 ANDA220972 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 84677-081-30 | 84677008130 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (84677-081-30) | 2026-09-09 | No | No | Current |